Treatment adherence by the numbers — a allergy and immunology snapshot

Recent studies suggest that variability between operators remains a key limitation, although confirmatory data are still limited. Longitudinal data show that real-world registries complement randomized trial evidence, a finding echoed by several independent groups. Emerging evidence indicates that threshold harmonization is still an open question, a finding echoed by several independent groups.

Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups. Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, particularly in resource-constrained settings. In multidisciplinary settings, training and accreditation are decisive for reproducibility, and this trend is expected to continue. Longitudinal data show that real-world registries complement randomized trial evidence, a finding echoed by several independent groups.

When protocols are compared, integrating quantitative measures reduces subjective bias, which has direct implications for daily practice. Contrary to earlier assumptions, patient selection criteria deserve closer scrutiny, although confirmatory data are still limited. Longitudinal data show that real-world registries complement randomized trial evidence, although confirmatory data are still limited.